Signaling by EGFR Signaling by EGFR in Cancer Authored: Orlic-Milacic, M, 2011-11-04 Edited: D'Eustachio, P, 2011-11-07 Edited: Gillespie, ME, 2011-11-07 Edited: Haw, R, 2011-11-07 Edited: Jassal, B, 2011-11-07 Edited: Matthews, L, 2011-11-07 Edited: Wu, G, 2011-11-07 Reactome Database ID Release 431643713 Reactome, http://www.reactome.org ReactomeREACT_115871 Reviewed: Greulich, H, 2011-11-15 Reviewed: Savas, S, 2011-11-15 The pathway "Signaling by EGFR in Cancer" shows "Signaling by constitutively active EGFR" in parallel with "Signaling by EGFR". This allows users to compare signaling by constitutively active EGFR cancer mutants with the wild-type EGFR protein. Red lines emphasize cancer related events and physical entities, while wild-type entities and events are shaded. Please refer to "Signaling by constitutively active EGFR" and "Signaling by EGFR" for detailed pathway summations. Signaling by constitutively active EGFR PathwayStep3927 PathwayStep3956